Literature DB >> 8301297

Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

A J Larner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8301297      PMCID: PMC485059          DOI: 10.1136/jnnp.57.1.126-a

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

1.  Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

Authors:  M Vrethem; T Skogh; J Ernerudh; B Ekstedt; O Andersen; J Lycke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

2.  Cyclosporin A therapy in paraprotein-associated neuropathy.

Authors:  J A Waterston; M M Brown; D A Ingram; M Swash
Journal:  Muscle Nerve       Date:  1992-04       Impact factor: 3.217

Review 3.  Recent advances in the understanding of the immunological basis of peripheral neuropathies.

Authors:  A J Larner
Journal:  Br J Clin Pract       Date:  1993 Sep-Oct

4.  Neuropathy associated with monoclonal gammopathies of undetermined significance.

Authors:  S Gosselin; R A Kyle; P J Dyck
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

5.  Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.

Authors:  P J Dyck; P A Low; A J Windebank; S S Jaradeh; S Gosselin; P Bourque; B E Smith; K M Kratz; J L Karnes; B A Evans
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

6.  Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.

Authors:  S Bansil; F A Mithen; S D Cook; A Sheffet; C Rohowsky-Kochan
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.